Literature DB >> 30069923

CYP2D6 allele frequencies, copy number variants, and tandems in the population of Hong Kong.

Wing Chan1, Man S Li1, Senthil K Sundaram1, Brian Tomlinson2, Pik Y Cheung1, Chi H Tzang1.   

Abstract

BACKGROUND: CYP2D6 plays a crucial role in drug metabolism of several drugs. It is known to be highly polymorphic with enzymatic activity ranging from poor to ultrarapid metabolic rates. While the frequencies of CYP2D6 alleles are generally known in different Asian populations, data on frequencies of the copy number variations (CNV) and tandems in CYP2D6 in which they occur are less well studied in these populations.
METHODS: A cohort of 800 consecutive, unrelated individuals were referred to Prenetics Limited (Prenetics) iGenes test by physicians in Hong Kong as part of their care with informed consent. These clinical samples were deidentified prior to further analysis. Genotyping and copy number determination of CYP2D6 were performed using target specific TaqMan® SNP genotyping and copy number assays. The phenotypes of CYP2D6 were predicted based on its genotypes and is dependent on the biallelic expression of alleles.
RESULTS: Among the Asian group (n = 735, 92%), the observed frequency of CYP2D6*36-*10 tandems was 34.1%. We also identified duplication of CYP2D6 alleles in 86 (11.7%) individuals of the study cohort. The frequency of all CYP2D6 duplicated alleles was 154 (10.5%) while only 28 (1.9%) of the duplications were of functional alleles (ie CYP2D6*1 and CYP2D6*2).
CONCLUSION: The present study provides a comprehensive analysis on the occurrences of CNV and tandems of the CYP2D6 gene in the Hong Kong population. The results contribute to the overall knowledge of pharmacogenomics and may accelerate the implementation of precision medicine in Asia.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990CYP2D6*36-*10zzm321990; CYP2D6 genotyping; copy number variations; drug metabolism; tandem repeats

Mesh:

Substances:

Year:  2018        PMID: 30069923      PMCID: PMC6430334          DOI: 10.1002/jcla.22634

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  32 in total

1.  Sequence-based analysis of the CYP2D6*36-CYP2D6*10 tandem-type arrangement, a major CYP2D6*10 haplotype in the Japanese population.

Authors:  Akiko Soyama; Yoshiro Saito; Takashi Kubo; Atsuko Miyajima; Yasuo Ohno; Kazuo Komamura; Kazuyuki Ueno; Shiro Kamakura; Masafumi Kitakaze; Hitonobu Tomoike; Shogo Ozawa; Jun-ichi Sawada
Journal:  Drug Metab Pharmacokinet       Date:  2006-06       Impact factor: 3.614

Review 2.  Pharmacogenetics, drug-metabolizing enzymes, and clinical practice.

Authors:  Sharon J Gardiner; Evan J Begg
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.

Authors:  A Gaedigk; S D Simon; R E Pearce; L D Bradford; M J Kennedy; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

Review 4.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.

Authors:  G C Bell; K E Caudle; M Whirl-Carrillo; R J Gordon; K Hikino; C A Prows; A Gaedigk; Jag Agundez; S Sadhasivam; T E Klein; M Schwab
Journal:  Clin Pharmacol Ther       Date:  2017-04-06       Impact factor: 6.875

5.  Frequency of human CYP2D6 mutant alleles in a normal Chinese population.

Authors:  E J Lee; K Jeyaseelan
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 6.  Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.

Authors:  J Brockmöller; J Kirchheiner; C Meisel; I Roots
Journal:  Pharmacogenomics       Date:  2000-05       Impact factor: 2.533

Review 7.  Pharmacogenetics: from bench to byte--an update of guidelines.

Authors:  J J Swen; M Nijenhuis; A de Boer; L Grandia; A H Maitland-van der Zee; H Mulder; G A P J M Rongen; R H N van Schaik; T Schalekamp; D J Touw; J van der Weide; B Wilffert; V H M Deneer; H-J Guchelaar
Journal:  Clin Pharmacol Ther       Date:  2011-03-16       Impact factor: 6.875

8.  Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates.

Authors:  Y Ramamoorthy; R F Tyndale; E M Sellers
Journal:  Pharmacogenetics       Date:  2001-08

9.  Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.

Authors:  J K Hicks; K Sangkuhl; J J Swen; V L Ellingrod; D J Müller; K Shimoda; J R Bishop; E D Kharasch; T C Skaar; A Gaedigk; H M Dunnenberger; T E Klein; K E Caudle; J C Stingl
Journal:  Clin Pharmacol Ther       Date:  2017-02-13       Impact factor: 6.875

Review 10.  Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.

Authors:  K R Crews; A Gaedigk; H M Dunnenberger; J S Leeder; T E Klein; K E Caudle; C E Haidar; D D Shen; J T Callaghan; S Sadhasivam; C A Prows; E D Kharasch; T C Skaar
Journal:  Clin Pharmacol Ther       Date:  2014-01-23       Impact factor: 6.875

View more
  5 in total

1.  CYP2D6 allele frequencies, copy number variants, and tandems in the population of Hong Kong.

Authors:  Wing Chan; Man S Li; Senthil K Sundaram; Brian Tomlinson; Pik Y Cheung; Chi H Tzang
Journal:  J Clin Lab Anal       Date:  2018-08-01       Impact factor: 2.352

2.  Measurements of 5,6-Orthoquinone, a Surrogate for the Presumed Active Primaquine Metabolite 5-Hydroxyprimaquine, in the Urine of Cambodian Adults.

Authors:  Pattaraporn Vanachayangkul; Darapiseth Sea; Mariusz Wojnarski; Somethy Sok; Chanikarn Kodchakorn; Winita Ta-Aksorn; Sohei Hom; Mali Ittiverakul; Worachet Kuntawunginn; Montri Arsanok; Nillawan Buathong; Thay Kheang Heng; Kong Nareth; Samon Nou; Sok Chandara; Sokna Ly; Pheaktra Oung; Brian Vesely; Jason Bennett; Gregory Reichard; Brandon Pybus; Charlotte Lanteri; David Saunders; Mark Fukuda; Philip Smith; Lek Dysoley; Huy Rekol; Norman C Waters; Michele Spring
Journal:  Antimicrob Agents Chemother       Date:  2022-01-03       Impact factor: 5.938

3.  Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.

Authors:  Mullin Ho Chung Yu; Marcus Chun Yin Chan; Claudia Ching Yan Chung; Andrew Wang Tat Li; Chara Yin Wa Yip; Christopher Chun Yu Mak; Jeffrey Fong Ting Chau; Mianne Lee; Jasmine Lee Fong Fung; Mandy Ho Yin Tsang; Joshua Chun Ki Chan; Wilfred Hing Sang Wong; Jing Yang; William Chun Ming Chui; Patrick Ho Yu Chung; Wanling Yang; So Lun Lee; Godfrey Chi Fung Chan; Paul Kwong Hang Tam; Yu Lung Lau; Clara Sze Man Tang; Kit San Yeung; Brian Hon Yin Chung
Journal:  PLoS Genet       Date:  2021-02-18       Impact factor: 5.917

4.  Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.

Authors:  Xiao Chen; Fei Shen; Nina Gonzaludo; Alka Malhotra; Cande Rogert; Ryan J Taft; David R Bentley; Michael A Eberle
Journal:  Pharmacogenomics J       Date:  2021-01-18       Impact factor: 3.245

Review 5.  A Review of the Important Role of CYP2D6 in Pharmacogenomics.

Authors:  Christopher Taylor; Ian Crosby; Vincent Yip; Peter Maguire; Munir Pirmohamed; Richard M Turner
Journal:  Genes (Basel)       Date:  2020-10-30       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.